American Medical Association (AMA) President Peter Carmel is refuting a New England Journal of Medicine (NEJM) article that insinuates the AMA has financial incentives to support a Supreme Court decision allowing the sale of prescription drug information to pharmaceutical companies, reports Information Week. The NEJM article also claims the AMA has not done enough to promote its program allowing doctors to opt out of data mining. But Carmel calls the assertions "unfounded speculation" and outlines ways the AMA has promoted the opt-out program. While the AMA believes physicians should have the right to opt out, the report states, it "prefers its own approach to state laws that might be overly restrictive."
If you want to comment on this post, you need to login.